Table 2 Summary of pooled estimates of indications and quality indicators of antimicrobial prescription in African health facilities
Variables | Number of facilities involved | Total sample size | Pooled estimates %(95%CI) | I2% | p-value | |
|---|---|---|---|---|---|---|
Indications | Treatment | 134 | 23,584 | 62(56–69) | 99 | < 001 |
Medical prophylaxis | 130 | 22,116 | 14(11–17) | 98.4 | < 001 | |
Surgical prophylaxis | 134 | 23,584 | 27(22–32) | 98.1 | < 001 | |
Hospital-acquired infections | 132 | 21,104 | 20(14–26) | 98.6 | < 001 | |
Quality indicators | Reasons in note | 80 | 18,877 | 64 (55–73) | 99.4 | < 001 |
Guideline compliance | 100 | 21,552 | 49(30–68) | 99 | < 001 | |
Stop/review date | 56 | 16,650 | 48(37–60) | 99.5 | < 001 | |
Targeted therapy | 93 | 21,364 | 10(8–13) | 97.4 | < 001 | |
Parenteral route | 113 | 22,886 | 65(50–80) | 99.9 | < 001 | |
Extended surgical prophylaxis | 106 | 18,345 | 87(83–91) | 96.5 | < 001 | |